Business headlines from the Apex backend, organized by sectors and major public companies for faster market scanning.
The company said it will post its Q3 2026 financial results and related materials on Thursday, October 8, covering the quarter ended September 5.
THE APEX TIMES
THE APEX TIMES
A Yahoo Finance recap of second-quarter results compares Exxon Mobil (NYSE: XOM) with other diversified upstream exploration and production peers as investors close out earnings season.
THE APEX TIMES
A Yahoo Finance roundup highlighted new Wall Street research activity across semiconductors, software, retail, and fintech, with Moderna included among the names covered.
THE APEX TIMES
A Yahoo Finance analysis argues that Alphabet’s growing use of custom chips from Marvell, alongside or instead of Broadcom, could intensify competition for Broadcom in key customer programs. The piece offers a framing more than new disclosures.
THE APEX TIMES
In its Q2 2027 earnings call discussion published by Yahoo Finance, Home Depot said demand is being supported by smaller projects, while affordability pressures are muting purchasing decisions tied to larger home improvements.
THE APEX TIMES
The semiconductor maker’s shares moved higher after Raymond James upgraded Advanced Micro Devices from Outperform to Strong Buy and raised its price target to $641 from $565.
THE APEX TIMES
The technology company says it has entered a multi-year partnership with Canada’s Major League Baseball franchise, expanding its presence in sports sponsorship and fan engagement.
THE APEX TIMES
Ahead of its upcoming results, Nvidia is expected to confront a central question for Wall Street, whether its next-generation Rubin platform can keep the pace of growth while analysts scrutinize the company’s approach to funding artificial intelligence infrastructure.
THE APEX TIMES
Moderna (NASDAQ:MRNA) shares rose in premarket trading, regaining some ground after a sharp run-up earlier associated with positive Phase 3 results for its personalized mRNA cancer vaccine program.
